Navigation Links
FDA Clears Volpara™ Breast Imaging Software for Automatic Calculation of Volumetric Breast Density
Date:11/18/2010

hich are becoming increasingly important as adjuvant imaging is being added to traditional screening mammography.

"Density has become a breast healthcare issue of increasing importance as Connecticut and at least seven other states have enacted or are considering density notification legislation. This was bolstered recently as Nancy Brinker, founder and CEO of Susan G. Komen for the Cure, expressed Komen's position that it should be regular practice for doctors to inform women of their breast density if their mammogram shows they have dense breast tissue, and that it is important for doctors to discuss with their patients with dense breasts what additional screening tools might be appropriate for them," said Gerald Kolb, vice president of Business Development for Volpara.

ABOUT VOLPARA

Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Limited is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand.  Volpara's founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK, Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford's most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.


'/>"/>
SOURCE Volpara, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain
2. FDA Clears Software Upgrade for Fenwal Plasma-Collection System
3. FDA Clears AirStrip RPM for CRITICAL CARE & CARDIOLOGY Remote Patient Monitoring Solutions
4. FDA Clears Xlumenas NAVIX(TM) Access Device
5. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
6. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
7. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
8. FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
9. U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
10. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
11. FDA Clears a Test for Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... A new analysis and infographic released ... Hepatitis C medications could range from hundreds of millions of ... Hepatitis C receive treatment through state programs. The analysis, which ... on public programs, comes at a time when state and ... Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Inari Medical, Inc. announced today that it has ... The financing was led by members of the board ... Venture Partners.  The round also included participation by several ... pleased to complete this financing with the support of ... who joined in February 2015 as President and Chief ...
(Date:6/30/2015)... 30, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical Company focused on the development of oral drug ... been screened in the Company,s Phase IIb trial of ... will be performed under the active Investigational New Drug ... Drug Administration (FDA). The Phase IIb study ...
Breaking Medicine Technology:New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3
... Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: ... updated the progress of its Phase II,clinical ... cancer patients who are unable to tolerate ... trial for first-line,treatment of biliary cancer patients. ...
... Late-breaking Phase III,clinical trial data presented today ... Haemostasis (ISTH) Congress demonstrate,that once-daily rivaroxaban achieved ... (VTE) in patients undergoing,knee replacement surgery in ... of care. Patients in the RECORD3,(REgulation of ...
Cached Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
(Date:6/30/2015)... (PRWEB) , ... July 01, 2015 , ... ... it more responsive and easy to navigate. By making fundamental changes to the ... A representative from the site said, “Finding the right website has been getting ...
(Date:6/30/2015)... ... ... is a reliable source for cheap tickets for Journey at the Stadium of Fire ... packing venues for years and they are one of the most beloved musical acts in ... While Journey is known for their all-around great sound, fans of the group will ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Blue Cross and Blue Shield ... projects across the state. The projects improve community health by focusing on the social ... and many are renewable for a second year in 2016 based on progress in ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
Breaking Medicine News(10 mins):Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4
... Facts About project offers answers( www.tenquestionstoanswer.org )WASHINGTON, May 27 ... facilities will find answers to the critical questions they ... ANSWER ABOUT LONG TERM CARE" released today by ... Facts About project.Teresa Heinz, chairman of ...
... AG (VSE: ICLL) today announced that it will webcast ... York on Thursday, June 4 starting at 12:00 p.m. ... meeting will focus on the applications we are pursuing ... Zettlmeissl, Chief Executive Officer of Intercell. "Our proprietary vaccine ...
... in Houston, Texas to be Site of Facing Mars ... 2009, the John P. McGovern Museum of Health & Medical ... premiere of Facing Mars . The exhibit features interactive ... launch rockets, "fly over" the Martian landscape and consider the ...
... Precyse Solutions, a leading provider of clinical documentation ... a two-year consulting and training agreement with IASIS ... includes peer-to-peer training regarding quality clinical documentation for ... its ability to utilize physician trainers to conduct ...
... on drugs to fix what healthy living would cure, researcher ... of eating right, exercising and keeping your weight down are ... report. , In fact, over the past two decades exercise ... and in the meantime obesity rates have soared, a new ...
... Recondo Technology, a leading provider of revenue cycle ... today announced the firm,s selection as one of ... as one of the top 100 companies playing ... http://www.newscom.com/cgi-bin/prnh/20090527/LA23009LOGO ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA89162LOGO ...
Cached Medicine News:Health News:New From the Heinz Family Philanthropies: 10 New Questions Families Should Ask Before Choosing Long-Term Care 2Health News:New From the Heinz Family Philanthropies: 10 New Questions Families Should Ask Before Choosing Long-Term Care 3Health News:Intercell to Webcast Research & Development Day on Thursday, June 4, 2009 2Health News:Intercell to Webcast Research & Development Day on Thursday, June 4, 2009 3Health News:If You Could Travel to Mars, Would You Go? 2Health News:If You Could Travel to Mars, Would You Go? 3Health News:IASIS Healthcare and Precyse Solutions Sign Two-Year Consulting Agreement 2Health News:IASIS Healthcare and Precyse Solutions Sign Two-Year Consulting Agreement 3Health News:Americans Score Low on Healthy Lifestyle 2Health News:Americans Score Low on Healthy Lifestyle 3Health News:Recondo Technology Wins Red Herring 100 North America Award 2
... Stainless steel spiral reinforced. X-ray opaque . Low ... Flange: The flange can be adjusted along the ... cervical soft tissue. The lock ring is turned ... the shaft. Maximum Patient Comfort: The tube is ...
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
Thermosensitivity of material allows tube to conform to patients anatomy for maximum patient comfort....
Medicine Products: